279 related articles for article (PubMed ID: 11280535)
1. Efficacy of cisapride and domperidone in functional (nonulcer) dyspepsia: a meta-analysis.
Veldhuyzen van Zanten SJ; Jones MJ; Verlinden M; Talley NJ
Am J Gastroenterol; 2001 Mar; 96(3):689-96. PubMed ID: 11280535
[TBL] [Abstract][Full Text] [Related]
2. Treatment of functional dyspepsia with serotonin agonists: a meta-analysis of randomized controlled trials.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Oct; 22(10):1566-70. PubMed ID: 17845684
[TBL] [Abstract][Full Text] [Related]
3. Meta-analysis of the effects of prokinetic agents in patients with functional dyspepsia.
Hiyama T; Yoshihara M; Matsuo K; Kusunoki H; Kamada T; Ito M; Tanaka S; Nishi N; Chayama K; Haruma K
J Gastroenterol Hepatol; 2007 Mar; 22(3):304-10. PubMed ID: 17295758
[TBL] [Abstract][Full Text] [Related]
4. [Pharmacologic and clinical differentiation of prokinetic drugs].
May B; Greving I
Leber Magen Darm; 1996 Jul; 26(4):193-8. PubMed ID: 8965601
[TBL] [Abstract][Full Text] [Related]
5. Study with two prokinetics in functional dyspepsia and GORD: domperidone vs. cisapride.
Halter F; Staub P; Hammer B; Guyot J; Miazza BM
J Physiol Pharmacol; 1997 Jun; 48(2):185-92. PubMed ID: 9223023
[TBL] [Abstract][Full Text] [Related]
6. Prokinetics for functional dyspepsia.
Pittayanon R; Yuan Y; Bollegala NP; Khanna R; Leontiadis GI; Moayyedi P
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD009431. PubMed ID: 30335201
[TBL] [Abstract][Full Text] [Related]
7. Levosulpiride in functional dyspepsia: a multicentric, double-blind, controlled trial.
Corazza GR; Biagi F; Albano O; Bianchi Porro G; Cheli R; Mazzacca G; Miglio F; Naccarato R; Quaglino D; Surrenti C; Verme G; Gasbarrini G
Ital J Gastroenterol; 1996; 28(6):317-23. PubMed ID: 8891846
[TBL] [Abstract][Full Text] [Related]
8. A randomized trial comparing omeprazole, ranitidine, cisapride, or placebo in helicobacter pylori negative, primary care patients with dyspepsia: the CADET-HN Study.
Veldhuyzen van Zanten SJ; Chiba N; Armstrong D; Barkun A; Thomson A; Smyth S; Escobedo S; Lee J; Sinclair P
Am J Gastroenterol; 2005 Jul; 100(7):1477-88. PubMed ID: 15984968
[TBL] [Abstract][Full Text] [Related]
9. Lack of effect of Helicobacter pylori on symptom improvement with a prokinetic medication, cisapride, in patients with non-ulcer dyspepsia.
Gonlachanvit S; Mahachai V; Chaiwatanarat T; Kullavanijaya P
J Med Assoc Thai; 2005 May; 88(5):660-7. PubMed ID: 16149685
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of cisapride in functional dyspepsia resistant to domperidone or metoclopramide: a double-blind, placebo-controlled study.
Van Outryve M; De Nutte N; Van Eeghem P; Gooris JP
Scand J Gastroenterol Suppl; 1993; 195():47-52; discussion 52-3. PubMed ID: 8516658
[TBL] [Abstract][Full Text] [Related]
11. [Combination therapy of azintamid and domperidone in functional dyspepsia: a randomised, double-blind, placebo-controlled trial].
Zhao L; Xu L; Li Q; Wang XD; Wang DM; Wang ZG
Zhonghua Nei Ke Za Zhi; 2011 Mar; 50(3):212-5. PubMed ID: 21600084
[TBL] [Abstract][Full Text] [Related]
12. Domperidone versus cisapride in the treatment of infant regurgitation and increased acid gastro-oesophageal reflux: a pilot study.
Hegar B; Alatas S; Advani N; Firmansyah A; Vandenplas Y
Acta Paediatr; 2009 Apr; 98(4):750-5. PubMed ID: 19076984
[TBL] [Abstract][Full Text] [Related]
13. A randomised clinical trial comparing the efficacy of a herbal preparation STW 5 with the prokinetic drug cisapride in patients with dysmotility type of functional dyspepsia.
Rösch W; Vinson B; Sassin I
Z Gastroenterol; 2002 Jun; 40(6):401-8. PubMed ID: 12055663
[TBL] [Abstract][Full Text] [Related]
14. Treatment of functional dyspepsia with a fixed peppermint oil and caraway oil combination preparation as compared to cisapride. A multicenter, reference-controlled double-blind equivalence study.
Madisch A; Heydenreich CJ; Wieland V; Hufnagel R; Hotz J
Arzneimittelforschung; 1999 Nov; 49(11):925-32. PubMed ID: 10604046
[TBL] [Abstract][Full Text] [Related]
15. Management of diabetic gastroparesis.
Mukhopadhyay P; Basu AK
J Indian Med Assoc; 2005 Mar; 103(3):184, 186. PubMed ID: 16173296
[TBL] [Abstract][Full Text] [Related]
16. Cisapride in the management of chronic functional dyspepsia: a multicenter, double-blind, placebo-controlled study.
Deruyttere M; Lepoutre L; Heylen H; Samain H; Pennoit H
Clin Ther; 1987; 10(1):44-51. PubMed ID: 3329964
[TBL] [Abstract][Full Text] [Related]
17. Domperidone is more effective than cisapride in children with diabetic gastroparesis.
Franzese A; Borrelli O; Corrado G; Rea P; Di Nardo G; Grandinetti AL; Dito L; Cucchiara S
Aliment Pharmacol Ther; 2002 May; 16(5):951-7. PubMed ID: 11966504
[TBL] [Abstract][Full Text] [Related]
18. Domperidone: a peripherally acting dopamine2-receptor antagonist.
Barone JA
Ann Pharmacother; 1999 Apr; 33(4):429-40. PubMed ID: 10332535
[TBL] [Abstract][Full Text] [Related]
19. Update on the role of drug therapy in non-ulcer dyspepsia.
Talley NJ
Rev Gastroenterol Disord; 2003; 3(1):25-30. PubMed ID: 12684590
[TBL] [Abstract][Full Text] [Related]
20. A double-blind randomized study of cisapride in the treatment of nonulcer dyspepsia. The Canadian Cisapride Nud Study Group.
Champion MC; MacCannell KL; Thomson AB; Tanton R; Eberhard S; Sullivan SN; Archambault A
Can J Gastroenterol; 1997 Mar; 11(2):127-34. PubMed ID: 9113812
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
